MedTrace Logo

Effects of Vivatlac Baby on Crying Behavior of Colicky Babies

NCT04487834 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2023-11-22

Study results available
· View outcomes & findings →

Summary

Open trial with two parallel arms, assessing the effects of Simethicone and Vivatlac Baby in babies diagnosed for infantile colic.

Conditions

  • Infantile Colic

Interventions

DRUG

Simethicone Solution

Oral daily treatment for four weeks

DIETARY_SUPPLEMENT

Vivatlac Baby

Oral daily treatment for four weeks

Sponsors & Collaborators

  • The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz

    lead OTHER

Principal Investigators

  • Hanna Krauss, Prof. · University of Applied Sciences in Kalisz, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Weeks
Max Age
6 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-16
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04487834 on ClinicalTrials.gov